Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Cryoablation system to expand Boston Sci's global profile in interventional oncology

Sep. 18, 2019

By David Godkin

Triumvira Immunologics cleared in U.S and Canada to conduct TAC01-CD19 studies

June 19, 2019

Lanadelumab submissions in E.U. and Canada accepted for review

March 29, 2018

Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer

Feb. 5, 2018

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

Health Canada gives priority review status to ProMetic's NDS for Ryplazim

Oct. 20, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

Health Canada approves Maviret for chronic HCV in all major genotypes

Aug. 18, 2017

Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV

Aug. 18, 2017

Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease

May 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...